Nanjing
688105.SSNanjing Vazyme Biotech Co., Ltd. Price (688105.SS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
394,201,330
(1.4521)%Income Statement Summary
| Revenue | |
| Cost of Revenue | |
| Gross Profit | |
| Operating Expenses | |
| Operating Income | |
| Other Expenses | |
| Net Income |
Income Statement
Nanjing Vazyme Biotech Co., Ltd.Currency: CNY
| YEAR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
112,372,334.00
+0% |
170,804,715.00
+52% |
268,380,113.00
+57% |
1,564,454,261.00
+483% |
1,868,627,293.00
+19% |
3,568,984,515.00
+91% |
1,285,988,243.00
-64% |
||||||||||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 22,378,431.00 | 29,844,045.00 | 42,084,793.00 | 133,632,482.00 | 350,847,707.00 | 1,110,510,955.00 | 514,886,181.00 | ||||||||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
89,993,903.00
+0% |
140,960,670.00
+57% |
226,295,320.00
+61% |
1,430,821,779.00
+532% |
1,517,779,586.00
+6% |
2,458,473,560.00
+62% |
771,102,062.00
-69% |
||||||||||||
| Gross Profit Ratio | (0.80%) | (0.83%) | (0.84%) | (0.91%) | (0.81%) | (0.69%) | (0.60%) | ||||||||||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 26,280,090.00 | 53,004,532.00 | 62,296,619.00 | 125,533,433.00 | 230,321,525.00 | 396,106,955.00 | 338,615,864.00 | ||||||||||||
| General and Administrative | 11,941,559.00 | 12,315,559.00 | 18,070,741.00 | 53,626,222.00 | 85,755,085.00 | 105,130,892.00 | 55,870,617.00 | ||||||||||||
| Selling, General & Admin... | 52,093,449.00 | 76,953,875.00 | 114,654,454.00 | 241,352,238.00 | 405,221,914.00 | 627,533,242.00 | 528,557,327.00 | ||||||||||||
| Selling & Marketing Exp... | 40,151,890.00 | 64,638,315.00 | 96,583,713.00 | 187,726,015.00 | 319,466,829.00 | 522,402,350.00 | 472,686,710.00 | ||||||||||||
| Depreciation and Amortiz... | 2,616,503.00 | 7,408,100.00 | 13,546,100.00 | 23,438,674.00 | 83,194,624.00 | 216,930,602.00 | 235,633,180.00 | ||||||||||||
| Other Expenses | -56,039.32 | -110,590.62 | 21,979,523.00 | 41,232,733.00 | 85,821,075.00 | 197,862,546.00 | 4,109,106.00 | ||||||||||||
| Total Operating Expenses | 90,162,200.00 | 137,518,997.00 | 198,930,597.00 | 408,118,404.00 | 721,364,515.00 | 1,221,502,744.00 | 871,282,297.00 | ||||||||||||
| Cost and Exponses | 112,540,631.00 | 167,363,043.00 | 241,015,391.00 | 541,750,887.00 | 1,072,212,223.00 | 2,332,013,700.00 | 1,386,168,478.00 | ||||||||||||
| Operating Income | |||||||||||||||||||
| Operating Income |
4,521.61
+0% |
526,121.00
+11,536% |
24,319,016.00
+4,522% |
973,015,778.00
+3,901% |
771,138,247.00
-21% |
1,198,465,619.00
+55% |
-100,180,235.00
-108% |
||||||||||||
| Operating Income Ratio | (0.00%) | (0.00%) | (0.09%) | (0.62%) | (0.41%) | (0.34%) | (-0.08%) | ||||||||||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | 214,924.00 | 623,097.00 | 224,828.00 | 658,253.00 | 3,170,477.00 | 23,291,006.00 | 52,358,187.00 | ||||||||||||
| Interest Expenses | 298,137.00 | 901,663.00 | 402,176.00 | 1,027,443.00 | 3,863,546.00 | 12,475,363.00 | 35,065,829.00 | ||||||||||||
| Total Other Income/Exp... | 0.00 | -110,591.00 | 49,893.00 | -13,757,288.00 | -6,693,223.00 | -108,104,045.00 | -15,534,023.00 | ||||||||||||
| EBITDA | |||||||||||||||||||
| EBITDA | 2,919,162.00 | 8,767,671.00 | 38,377,041.00 | 983,886,810.00 | 853,116,413.00 | 841,803,574.00 | 156,125,192.00 | ||||||||||||
| EBITDA ratio | (0.05%) | (0.05%) | (0.13%) | (0.66%) | (0.47%) | (0.37%) | (0.12%) | ||||||||||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | 4,521.61 | 415,530.00 | 24,368,909.00 | 959,258,490.00 | 764,445,018.00 | 609,389,800.00 | -115,714,258.00 | ||||||||||||
| Income Before Tax Ratio | (0.00%) | (0.00%) | (0.09%) | (0.61%) | (0.41%) | (0.17%) | (-0.09%) | ||||||||||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | -3,640,036.33 | -623,182.18 | -1,425,915.67 | 137,533,442.00 | 86,155,449.00 | 15,882,944.00 | -42,852,289.00 | ||||||||||||
| Net Income | |||||||||||||||||||
| Net Income | 3,644,557.00
+0% |
1,038,712.00
-71% |
25,794,825.00
+2,383% |
821,725,047.00
+3,086% |
678,289,569.00
-17% |
594,245,543.00
-12% |
-70,956,239.00
-112% |
||||||||||||
| Net Income Ratio | (0.03%) | (0.01%) | (0.10%) | (0.53%) | (0.36%) | (0.17%) | (-0.06%) | ||||||||||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | 0.01 | 0.00 | 0.06 | 2.05 | 1.70 | 1.49 | -0.18 | ||||||||||||
| Diluted EPS | 0.01 | 0.00 | 0.06 | 2.05 | 1.70 | 1.49 | -0.18 | ||||||||||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 355,725,129.00 | 355,725,129.00 | 400,010,000.00 | 400,010,000.00 | 400,010,000.00 | 400,010,000.00 | 394,201,330.00 | ||||||||||||
| Diluted Share Outstanding | 355,725,129.00 | 355,725,129.00 | 400,010,000.00 | 400,010,000.00 | 400,010,000.00 | 400,010,000.00 | 394,201,330.00 | ||||||||||||